Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is better than no deal at all with Florida. They are definitely good for the brand and reputation. If you can’t beat em get em on your team.
Thanks. I missed that in your original post.
What news channel? I want to see if there is a link with the video online.
Good publicity for the brand.
There’s Canadian companies with those revenues trading at $3-10B market caps and the potential in the US is significantly larger. California alone has more population than Canada.
I agree. I sold 1/3 first at $21.65 and another 1/3 at $24.65. I think it goes to ~$15 after financials. Then I sold 1/6 at $22.38. So I’m sitting on 1/6 for the long run that I originally paid $0.62 for 09/2016. Most likely won’t add back here. All Canadian is over valued simply because of legalization. I’m betting that US passes a law delisting cannabis off federal illegal and leaves it up to the states like alcohol. Then US companies will follow same pattern as Canadian did past 2 years and the upside is much higher when comparing population and potential of Canada to US. There’s companies in US doing same revenue as these Canadian companies right now.
Do they have to be silent because of late financials? For example IF the Cali labs are open, they can’t PR until financials are released?
Price is still higher than when you said that last week..
Appreciate it.
OS. Thanks.
What’s the share structure here? Link? Looked on OTC but says pink and no info.
Thanks for your response. Agree completely.
Who would your ideal partner/shark/buy out be? Tobacco? Big Pharma? Alcohol? Tech? McDonald’s? Coca Cola? Johnson and Johnson?
They all have pros and cons depending on how you think cannabis will be regulated (at gas stations like beer and tobacco, or state regulated dispensaries like ABC for liquor in some states, at a pharmacy, over the counter) and where the best market will be (buds, extracts, cbd, topicals, drinks, synthetic thc, edibles).
I thought big pharma for their standards, scientist, and tech but they have a bad reputation and would damper cannabis.
I though tobacco because linear production and growing assets (greenhouses etc) and recognizable brands in boxes for pre rolls etc but not sure it’ll be regulated and sold that way.
I believe with the way dispensaries are it will be more like liquor and ABC stores in some states.
Johnson and Johnson for topical and hemp?
I can’t find much benefit in Coca-Cola or McDonald’s. Other than huge brand recognition and world distribution. Scaling?
I’m trying to figure out who has the best partner/investor/shark.
Looking for other thought out mindful opinions.
Just starting looking into this. Good to see you’re over here!
I was thinking about potential buyouts today. I asked my girlfriend if she was a cannabis company who would she feel would be the best “shark”? I was more asking for Canadian cultivators. What would be most important? Coca-Cola and McDonalds are probably the best known WORLD wide brand but what else do they bring to the table? Would tobacco companies be best for cultivators? What else does alcohol bring to the table for cultivators? Big pharma?
Quest seems to be best for here IMO. No big pharma has been rumored anywhere that I know of. I think they would be good for a Canadian cultivator or tester. So I think Bayer and Pfizer would be looking.
But EVIO is a long ways away from a buyout IMO. We need more international expansion and international/import/export testing laws. These big Canadian cultivators are attractive for their global partnerships and exporting which help with scaling.
New math? $3M revs with 15x p/e is $45M. I never stated a share price here.
You used same numbers previously and were over $1 with your fair market value AFTER fully cashed in toxic financing.
I’m saying the numbers don’t even matter at this point because the call has been dropped multiple times.
I get it. I’ve read your posts daily. I agree with a lot of what you say. These small things don’t show legitimacy or professionalism. And all that negates the numbers.
We need investor confidence. We are significantly under valued with $3.2M in revenues. Should be ~$45M market cap. We need timely filings and updates. Updates when things are late or changes in timelines. Cali labs that I thought were suppose to be opened by Q1, share structure reduction, and general market updates that directly impact us. We haven’t heard about Q1 revenues yet. Is there a date on when Canadian lab will be expanded?
lol no I’m serious. I’m trying to set a reminder for before earnings.
I found a $12.13 article but $1.8B for 45% doesn’t equal that.
https://www.google.com/amp/s/investorplace.com/2018/12/cronos-stock-investors-altria-buyout/amp/
Do you have a link?
$1.8B for 45% is $4B market cap. We are at $2.7B.
https://www.streetinsider.com/dr/news.php?id=14901039
CRON needs $266M yearly revenue to fulfill a $4B market cap at 15x p/e. Which is about $27/share which is what MO paid for their 45%. Do those Canada sales numbers include exporting revenue? I get $45 million x 12 = $540M x 15 p/e = $8.1B in total market cap for the first month. Do you not think there will be growth in the market globally (and even within Canada vs the black market as it shrinks and is battled against) and these companies are well positioned to be global leaders? Is Cannabis not as big as alcohol and tobacco with $80B world wide market caps per company? P/E are higher than 15 because the growth and dominance in these companies look promising especially with big global alcohol and tobacco companies putting and PAYING $4B valuations.
I’m following the money, if MO will pay $27 a share for CRON they obviously see a huge value in their partnership and US going legal with cannabis or a huge opportunity within US hemp.
https://www.streetinsider.com/dr/news.php?id=14901039
Earnings*
When is next warning report?
Agree with you on that.
I get all that and agree too. Many set backs and many mistakes. I agree with broth too they own many shares and should be “sacrificing” a bit more now until they are atleast in the green and profitable and they have huge incentive with the shares they own.
My pay, benefits, and bonuses for myself and employees is strictly a formula and I’m clear on what needs to be done for the formula to work. I don’t believe in paid for time but paid for work achieved and gross profit generated.
They counted their chickens before they hatched.. and miscounted with again millions on dollars and shares wasted on labs that are now closed.
I hope they can learn from these mistakes and do better. I still believe we are on the brink of success if we can iron out the kinks and not make the same mistakes going forward (which is clearly a problem).
I can say that employees now a days have different focus and work ethic than in the past. Technology trains our minds differently to not be as self sufficient and think proactively. Also a distraction as young generations have tablets in their hands out the womb. Comparing lifestyles and the need to have a new phone, clothes, etc is a real problem in what “livable” pay is for the work provided. Living within our means is something completely different now. All based on my experience as a business owner. I can talk about this all day. Slightly off topic but it’s a trend everywhere.
http://imgur.com/8Wo3Bz8
Honestly I think $150,000 is steep for a CEO who’s made many mistakes and seems to be inexperienced, can’t get financials out on time, and wasted millions of dollars in shares on labs that are closed for multiple different reasons. I think $100,000 is more than enough and the other $100,000 between both could be used to get better employees or used as incentive by putting goals in place to be hit with pay. That’s what I found works with my employees. Keeps moral and teamwork up. In turn the share price may be higher and everyone including them would get paid. But I also don’t think that is really the issue and kind of irrelevant because $100,000 won’t make or break the company from a financial standpoint. They could have had that meeting and lowered share count for that much. That much is car expenses and flights and possible 50% of many meals paid for by business and at minimum a depreciation.
The real issue is when are these Cali lease labs going to be generating revenue?!
I can look at the chart and agree there will be profit taking and pull back but support is above $10 when MO paid $27.30 a share. Same thing was said with CGC when it was at $11 and Constellation paid about $27 for it too. In the not so long term this is $30. IMO.
I know RSI is high and may have some profit taking but I don’t think we go back to $10. Especially with the farm bill and Altria is the only US Tobacco invested with a Canadian Cannabis company. In the long run we are headed to $27. IMO.-
Altria paid $1.8B for 45% which is about a $4B market cap. That is a share price of $27.30.
And the tickers were diff.
1,700 of CRON. I bought about $1,000 worth of CRON, CGC, and ACB in Sept 2016. As well as a few others. It was basically all the money I had at that time and my first self researched and educated investments.
My first buy was $0.62 9/19/16.
Dr. Cindy Orser Chief Science Officer on DigiPath will be speaking at this testing expo.
https://expo.analyticalcannabis.com/agenda
I don’t see EVIO on here but this is a testing expo. I am considering attending.
https://expo.analyticalcannabis.com/agenda
Have to agree on that as well. He should have addressed that over the mass lab. Also should have addressed the two California lease build outs.